Shares of Compass Pathways (NASDAQ: CMPS) were soaring 21.7% as of 12:26 p.m. EDT on Monday. The big jump came after short-seller Citron Research published a report online recommending the mental health company's stock.
Citron Research is primarily known for attacking stocks that it maintains have significant problems. But the short-seller views Compass Pathways as "the most compelling IPO of the year whose significance to humanity has the potential to be a generational stock."
Image source: Getty Images.
For further details see:
Why Compass Pathways Stock Is Soaring Today